Fast Radius, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022025107 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $133.2K
YoY Change
Cash & Equivalents $21.39M $133.2K
Short-Term Investments
Other Short-Term Assets $725.5K
YoY Change
Inventory $443.0K
Prepaid Expenses
Receivables $7.158M
Other Receivables
Total Short-Term Assets $33.58M $858.7K
YoY Change 3810.81%
LONG-TERM ASSETS
Property, Plant & Equipment $11.12M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $345.0M
YoY Change
Other Assets $3.051M $260.4K
YoY Change 1071.66%
Total Long-Term Assets $14.17M $345.3M
YoY Change -95.9%
TOTAL ASSETS
Total Short-Term Assets $33.58M $858.7K
Total Long-Term Assets $14.17M $345.3M
Total Assets $47.75M $346.1M
YoY Change -86.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.083M $195.4K
YoY Change 2501.38%
Accrued Expenses $1.355M
YoY Change
Deferred Revenue $164.0K
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $26.75M
YoY Change
Total Short-Term Liabilities $52.65M $2.070M
YoY Change 2443.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $59.00K $24.49M
YoY Change -99.76%
Total Long-Term Liabilities $59.00K $24.49M
YoY Change -99.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.65M $2.070M
Total Long-Term Liabilities $59.00K $24.49M
Total Liabilities $53.19M $26.56M
YoY Change 100.28%
SHAREHOLDERS EQUITY
Retained Earnings -$237.3M -$26.77M
YoY Change 786.28%
Common Stock $231.9M $1.362M
YoY Change 16922.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.437M -$25.41M
YoY Change
Total Liabilities & Shareholders Equity $47.75M $346.1M
YoY Change -86.2%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001832351
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40032
dei Entity Registrant Name
EntityRegistrantName
Fast Radius, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3692788
dei Entity Address Address Line1
EntityAddressAddressLine1
113 N. May Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60607
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
319-1060
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75901646
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21391000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8702000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1637000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
930000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7158000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7015000
CY2022Q3 us-gaap Inventory Net
InventoryNet
443000
CY2021Q4 us-gaap Inventory Net
InventoryNet
449000
CY2022Q3 fsrd Prepaid Production Costs
PrepaidProductionCosts
704000
CY2021Q4 fsrd Prepaid Production Costs
PrepaidProductionCosts
987000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3886000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4422000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
33582000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
21575000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11119000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9528000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3051000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
535000
CY2022Q3 us-gaap Assets
Assets
47752000
CY2021Q4 us-gaap Assets
Assets
31638000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5083000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3987000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4497000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3097000
CY2022Q3 fsrd Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
12400000
CY2021Q4 fsrd Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
11610000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
164000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
258000
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3750000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2513000
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2968000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
26752000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
13266000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
52646000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37699000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
59000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
396000
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
484000
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16776000
CY2022Q3 fsrd Related Party Convertible Notes And Derivative Liabilities Noncurrent
RelatedPartyConvertibleNotesAndDerivativeLiabilitiesNoncurrent
0
CY2021Q4 fsrd Related Party Convertible Notes And Derivative Liabilities Noncurrent
RelatedPartyConvertibleNotesAndDerivativeLiabilitiesNoncurrent
16857000
CY2022Q3 us-gaap Liabilities
Liabilities
53189000
CY2021Q4 us-gaap Liabilities
Liabilities
71728000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75901646
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39656951
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
8000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
231854000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
83399000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-237299000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123493000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5437000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-40090000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47752000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31638000
CY2022Q3 us-gaap Revenues
Revenues
7072000
CY2021Q3 us-gaap Revenues
Revenues
4916000
us-gaap Revenues
Revenues
20609000
us-gaap Revenues
Revenues
13579000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
6372000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
7049000
us-gaap Cost Of Revenue
CostOfRevenue
19016000
us-gaap Cost Of Revenue
CostOfRevenue
14077000
CY2022Q3 us-gaap Gross Profit
GrossProfit
700000
CY2021Q3 us-gaap Gross Profit
GrossProfit
-2133000
us-gaap Gross Profit
GrossProfit
1593000
us-gaap Gross Profit
GrossProfit
-498000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3674000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6583000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15887000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15335000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15162000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6006000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68104000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22501000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2255000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
461000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7484000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3148000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
21091000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
13050000
us-gaap Operating Expenses
OperatingExpenses
91475000
us-gaap Operating Expenses
OperatingExpenses
40984000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-20391000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15183000
us-gaap Operating Income Loss
OperatingIncomeLoss
-89882000
us-gaap Operating Income Loss
OperatingIncomeLoss
-41482000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-690000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
474000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7311000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1526000
CY2022Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
0
CY2021Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-195000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
30000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-189000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
126000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
156000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2022Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
2603000
CY2021Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1238000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
6580000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
1787000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22178000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17093000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88965000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44984000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22178000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17093000
us-gaap Net Income Loss
NetIncomeLoss
-88965000
us-gaap Net Income Loss
NetIncomeLoss
-44984000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.09
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76670955
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76670955
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41686939
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41686939
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71368336
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71368336
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41341537
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41341537
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22405000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12786000
CY2021Q1 fsrd Stock Issued During Period Value Stock Options Exercised And Release Of Notes Recourse Provision
StockIssuedDuringPeriodValueStockOptionsExercisedAndReleaseOfNotesRecourseProvision
9000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
254000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
9882000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-15105000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2201000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
276000
CY2021Q2 fsrd Stock Issued During Period Value Stock Options Exercised And Release Of Notes Recourse Provision
StockIssuedDuringPeriodValueStockOptionsExercisedAndReleaseOfNotesRecourseProvision
7000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
207000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2808000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17093000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2245000
CY2021Q3 fsrd Stock Issued During Period Value Stock Options Exercised And Release Of Notes Recourse Provision
StockIssuedDuringPeriodValueStockOptionsExercisedAndReleaseOfNotesRecourseProvision
25000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
239000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-17392000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-40090000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44600000
CY2022Q1 fsrd Effect Of Business Combination And Recapitalization Net Of Redemptions And Issuance Costs
EffectOfBusinessCombinationAndRecapitalizationNetOfRedemptionsAndIssuanceCosts
3030000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75000000
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
17655000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
63000
CY2022Q1 fsrd Warrants Exercised Value
WarrantsExercisedValue
1020000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20368000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
32446000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-22187000
CY2022Q2 fsrd Adjustment To Additional Issuance Of Common Stock For Settlement Of Bonus Liability
AdjustmentToAdditionalIssuanceOfCommonStockForSettlementOfBonusLiability
696000
CY2022Q2 fsrd Stock Issued During Period Value Commitment Shares
StockIssuedDuringPeriodValueCommitmentShares
452000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
148000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2562000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
14117000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22178000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
65000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2559000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5437000
us-gaap Profit Loss
ProfitLoss
-88965000
us-gaap Profit Loss
ProfitLoss
-44984000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2050000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1029000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4594000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1232000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
707000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
242000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-190000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-228000
us-gaap Share Based Compensation
ShareBasedCompensation
25489000
us-gaap Share Based Compensation
ShareBasedCompensation
700000
fsrd Issuance Of Commitment Shares To Lincoln Park
IssuanceOfCommitmentSharesToLincolnPark
452000
fsrd Income From Settlement Of Bonus Liability With Rsus
IncomeFromSettlementOfBonusLiabilityWithRsus
554000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7311000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1526000
fsrd Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-30000
fsrd Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
189000
fsrd Non Cash Asset Impairments
NonCashAssetImpairments
153000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
850000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1341000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6000
fsrd Increase Decrease In Prepaid Production Costs
IncreaseDecreaseInPrepaidProductionCosts
-283000
fsrd Increase Decrease In Prepaid Production Costs
IncreaseDecreaseInPrepaidProductionCosts
1042000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3090000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2186000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
995000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
684000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3732000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9619000
fsrd Increase Decrease In Advances From Customers
IncreaseDecreaseInAdvancesFromCustomers
-94000
fsrd Increase Decrease In Advances From Customers
IncreaseDecreaseInAdvancesFromCustomers
190000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2660000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
111000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-72367000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34306000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4493000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6437000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
763000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3730000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6437000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
276000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
40000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
24487000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
122000
fsrd Effect Of Merger Net Of Transaction Costs Paid
EffectOfMergerNetOfTransactionCostsPaid
22517000
fsrd Proceeds From Issuance Of Pipe Shares
ProceedsFromIssuanceOfPipeShares
75000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7625000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
803000
fsrd Deferred Financing Fees
DeferredFinancingFees
500000
fsrd Payment Of Deferred Underwriting Fees
PaymentOfDeferredUnderwritingFees
1382000
fsrd Proceeds From Convertible Notes And Warrants With Related Parties
ProceedsFromConvertibleNotesAndWarrantsWithRelatedParties
-10600000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
88786000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33702000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
12689000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7041000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8702000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18494000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21391000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11453000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
340000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
411000
fsrd Issuance Of Liability Classified Warrants
IssuanceOfLiabilityClassifiedWarrants
988000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates in Condensed Consolidated Financial Statements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the consolidated interim financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, related disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses for the periods presented. The Company’s most significant estimates and judgements involve valuation of the Company’s debt and equity securities (prior to the Business Combination), including assumptions made in the fair value of warrants, derivatives, and stock-based compensation; the useful lives of fixed assets; and allowances for doubtful accounts. Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if these results differ from historical experience or other assumptions prove not to be substantially accurate, even if such assumptions are reasonable when made.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other than the below, there have been no material changes to the Company's significant accounting policies from its audited consolidated financial statements included as Exhibit 99.1 to the Company’s Form 8-K/A filed with the SEC on March 30, 2022.</span></p>
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15516639
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
fsrd Warrants Expiration Date
WarrantsExpirationDate
2027-02-04
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant Customers and Concentration of Credit Risks</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is subject to credit risk primarily through its accounts receivable. Credit is generally extended to customers based on a credit review. The credit review considers each customer’s financial condition, including the customer’s established credit rating or the Company’s assessment of the customer’s creditworthiness based on their financial statements absent a credit rating, local industry practices, and business strategy. A credit limit and terms are established for each customer based on the outcome of this review. The Company performs on-going credit evaluations of its customers and maintains allowances for potential credit losses which, when realized, have been within the range of management’s expectations. The Company generally does not require collateral. The Company regularly evaluates the credit risk of its customers.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant customers are those that represent more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company’s total revenue or accounts receivable. For the three and nine months ended September 30, 2022 and 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> single customer accounted for more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company's revenue. As of September 30, 2022 and December 31, 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> single customer accounted for more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company's accounts receivable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
fsrd Concentration Of Risk Customer Benchmark
ConcentrationOfRiskCustomerBenchmark
0.10
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1499000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
696000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
930000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
405000
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
138000
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-46000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
707000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
242000
CY2021Q3 fsrd Allowance For Doubtful Accounts Receivable Written Off Recoveries
AllowanceForDoubtfulAccountsReceivableWrittenOffRecoveries
39000
fsrd Allowance For Doubtful Accounts Receivable Written Off Recoveries
AllowanceForDoubtfulAccountsReceivableWrittenOffRecoveries
36000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1637000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
611000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1637000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
611000
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
388000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
433000
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
55000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
16000
CY2022Q3 us-gaap Inventory Net
InventoryNet
443000
CY2021Q4 us-gaap Inventory Net
InventoryNet
449000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16219000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12853000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5100000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3325000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11119000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9528000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
26752000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
49907000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
0
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
7403000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
26752000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
42504000
CY2022Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0
CY2021Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
4395000
CY2022Q3 fsrd Long Term Debt And Derivative Liabilities
LongTermDebtAndDerivativeLiabilities
26752000
CY2021Q4 fsrd Long Term Debt And Derivative Liabilities
LongTermDebtAndDerivativeLiabilities
46899000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote per share
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75900000
CY2022Q3 fsrd Rsus Vested Not Yet Been Settled And Issued
RsusVestedNotYetBeenSettledAndIssued
1700000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
32900000
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15516667
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15516639
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
fsrd Warrants Expiration Date
WarrantsExpirationDate
2027-02-04
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2022Q3 us-gaap Revenues
Revenues
7072000
CY2021Q3 us-gaap Revenues
Revenues
4916000
us-gaap Revenues
Revenues
20609000
us-gaap Revenues
Revenues
13579000
fsrd Business Combination Valuation Trigger Amount
BusinessCombinationValuationTriggerAmount
1500000000
fsrd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Probability Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityRate
0.95
fsrd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Remain Private Probability Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRemainPrivateProbabilityRate
0.05
fsrd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Market Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMarketValue
736000000
fsrd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Conversion Ratio
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsConversionRatio
0.02056
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0071
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y4M24D
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25500000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
1000000.0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-22178000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17093000
us-gaap Net Income Loss
NetIncomeLoss
-88965000
us-gaap Net Income Loss
NetIncomeLoss
-44984000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76670955
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76670955
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41686939
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41686939
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71368336
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71368336
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41341537
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41341537
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.09
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11000000
CY2021Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
3153000
fsrd Deferred Fees Associated With Business Combination
DeferredFeesAssociatedWithBusinessCombination
11000000

Files In Submission

Name View Source Status
0000950170-22-025107-index-headers.html Edgar Link pending
0000950170-22-025107-index.html Edgar Link pending
0000950170-22-025107.txt Edgar Link pending
0000950170-22-025107-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fsrd-20220930.htm Edgar Link pending
fsrd-20220930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fsrd-20220930_cal.xml Edgar Link unprocessable
fsrd-ex31_1.htm Edgar Link pending
fsrd-ex31_2.htm Edgar Link pending
fsrd-ex32_1.htm Edgar Link pending
fsrd-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
fsrd-20220930_lab.xml Edgar Link unprocessable
fsrd-20220930_pre.xml Edgar Link unprocessable
fsrd-20220930_htm.xml Edgar Link completed
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fsrd-20220930_def.xml Edgar Link unprocessable